Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

FDA: Biowaiver on lower strengths [Regulatives / Guidelines]

posted by Yura – Belarus, 2018-05-25 12:22 (2528 d 11:13 ago) – Posting: # 18815
Views: 2,747

Hi John,
The biowaiver for lower dosages (T1, T2) is administered with the dosage (T), which participated in the bioequivalent study.
with respect

Complete thread:

FDA: Biowaiver on lower strengths jag009 2018-05-24 03:26 [Regulatives / Guidelines]
- FDA: Biowaiver on lower strengths wienui 2018-05-24 15:25
- FDA: Biowaiver on lower strengthsYura 2018-05-25 10:22
  - FDA: Biowaiver on lower strengths Yura 2018-05-26 17:21

Admin contact
23,424 posts in 4,927 threads, 1,668 registered users;
25 visitors (0 registered, 25 guests [including 1 identified bots]).
Forum time: 23:36 CEST (Europe/Vienna)

A drug is that substance which, when injected into a rat,
will produce a scientific report. Anonymous

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz